Good morning, Elyse. It’s Eric Steigerwalt. So, let me answer that question. And then, I’m going to actually add a little maybe longer term strategic context for everybody. First, it’s not bad often that we have equity markets like October. But, as long as markets do reasonably well for the rest of the year, I think that range is still appropriate. That’s why we broke out the excess returns in the presentation for the third quarter, so that you can get a sense of how, slightly abnormal markets affect us. Now, obviously, it will take a pretty good market to be at the top of the range. More importantly, on our December investor call, we will talk about like a longer term base case earnings growth percentage. Okay? And we expect that to be in the higher range than our current mid to high single digits. So, we’ll talk about that in early December. And we’re going to lay out our expense plans, our investment portfolio repositioning and our product strategy, so that you’ll see the drivers of that EPS growth. I might as well just add because I know the question is coming here. With respect to assets above CTE98, post the third quarter, so post October, roughly where we stand today, we believe we’re still well in excess, despite the October equity market performance. However, again, it might be valuable to make a few strategic comments. As Anant said, and as we said before, actually, in the near future, in 2019, we intend to begin operating within a range of RBC levels. And I’m looking forward to discussing that with you, as soon as we can. As I’ve said before, we intend to be a consistent returner of capital across market cycles. And all of our efforts are centered around being able to adopt VA capital form in 2019 to that end. So, I hope I answered your actual question. But, I thought that that additional strategic context might help everybody.